Our Clinical Product History

In 50 years, technology and innovation has pushed forward the field of in vitro diagnostics. Just look at the images and see how far we have come in just a short time! bioMérieux is proud to have played a part in helping you provide ever more relevant and faster results to improve patient management and healthcare. Our partnership approach with customers enables us to see where you need help most and that’s where we work hard to find new products, services or solutions.

 

1967

The Fibrometer is added to the BD Mérieux catalog, and is quickly adopted by a quarter (approx. 1,000) of Frace’s laboratories

 

1969

The first toxoplasmosis detection kit (diagnosis of toxoplasmosis by immunofluorescence)
Launch of miniaturized API® strip by 
API®System*

 

1972

Production and sale of the first ready-to-use culture media in Petri plates

 

1974

Launch of the SLIDEX® Meningitis kit (first test enabling the diagnosis of an infectious disease without prior culture, with results in 5 minutes compared to several days previously)

 

1979

First ATBTM Antibiotic Susceptibility test strip by API®System*

 

1985

First HIV screening test: VIRONOSTIKA® HIV anti-HTLV-III by Organon Teknika*

 

1989

Development of chromogenic media (culture media that enables identification of microbial colonies by coloring them). Today the range is called CHROMID®.

 

1990

Acquisition of the BOOM extraction and NASBA amplification technologies for molecular diagnostics

 

1991

Launch of the VIDAS® with 8 initial kits (today VIDAS® has close to 100 parameters)

 

1992

VIDAS® automated immunoassay platform adapted for industrial applications

 

1995

VIDAS® D-Dimer ExclusionTM is the first test used to rule out the diagnosis of deep vein thrombosis and pulmonary embolism to be certified by the FDA

 

1997

Launch of:
BacT/ALERT® 3D, an advanced automated system for the detection of microbial agents from Organon Teknika*
VITEK® 2, automated bacterial identification and antibiotic susceptibility testing system

 

2002

NUCLISENS® EASYQ® (molecular diagnostics platform for amplification and real-time detection)

NUCLISENS® EASYQ® HIV-1: the first real-time test for measuring HIV-1 viral load

 

2004

Launch of VITEK® 2 Compact

 

2009

Launch of PREVI® Isola for the automated inoculation of culture media, and PREVI® Color Gram for automated Gram staining

 

2010

BACT/ALERT® 3D Dual-T, a microbial detection system used for sterility testing in the biopharmaceutical industry
Launch of Myla® middleware

 

2011

Inauguration of the laboratory of the future, at Marcy l’Étoile, France (over 1,000 visits from biologists and scientists in a year). Development of a similar unit in Saint Louis, Missouri (USA).
The laboratories enable discussions to align bioMérieux’s future products and services with customer needs
 
Launch of CE-marked VITEK® MS, used in association with the VITEK®2 system for antibiotic susceptibility testing
 
First bioNexia® rapid tests commercialized by bioMérieux

 
2012
 
Launch of VITEK®MS, a bacterial identification system using MALDI-TOF mass spectrometry, for industrial applications
Presentation of VIDAS® 3, the new generation of the VIDAS® immunoassay platform
 
2013
 
FDA approval of novel molecular test, THxID-BRAF, a companion test for late stage metastatic melanoma tumor samples

HxIDTM-BRAFTHxID-BRAF, a companion diagnostic test for late stage metastatic melinoma tumor samplesmarkers  D VITEK®MS, a bacterial identification system using MALDI-TOF mass spectrometry, for industrial applications
 

 

*Api System was acquired by bioMérieux in 1987; Organon Teknika was acquired by bioMérieux in 2001

Quick Search
What are you looking for?
  • Our products
  • Our solutions
Pioneering diagnostics